HLA class II polymorphism in Latin American patients with multiple sclerosis

Autoimmunity Reviews

Volumn 9, Issue 6, 2010, Pages 407-413

  Rojas, Olga Lucía ^a   Rojas Villarraga, Adriana ^a   Cruz Tapias, Paola ^a   Sánchez, Jorge Luis ^b   Suárez Escudero, Juan Camilo ^b   Patarroyo, Manuel Alfonso ^a,c   Anaya, Juan Manuel ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b INDEA   (Colombia)

^c FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

Author keywords

HLA antigens; Latin America; Meta analysis; Multiple sclerosis; Myelin basic protein

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MYELIN BASIC PROTEIN;

ADULT; ALLELE; ANTIGEN BINDING; CASE CONTROL STUDY; COLOMBIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE IDENTIFICATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; REVIEW; RISK;

AUTOANTIGENS; CASE-CONTROL STUDIES; COLOMBIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PROTEIN BINDING; RISK FACTORS;

EID: 77949917895     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.11.001     Document Type: Review

References (40)

1. Hincapié-Zapata M.E., Suárez-Escudero J.C., Pineda-Tamayo R., and Anaya J.M. Quality of life in multiple sclerosis and other chronic autoimmune and non-autoimmune diseases. Rev Neurol 48 (2009) 225-230
2. Walsh E.C., Guschwan-McMahon S., Daly M.J., Hafler D.A., and Rioux J.D. Genetic analysis of multiple sclerosis. J Autoimmun 21 (2003) 111-116
3. Chao M.J., Barnardo M.C., Lui G.Z., Lincoln M.R., Ramagopalan S.V., Herrera B.M., et al. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium. Hum Mol Genet 16 (2007) 1951-1958
4. Etzensperger R., McMahon R.M., Jones E.Y., and Fugger L. Dissection of the multiple sclerosis associated DR2 haplotype. J Autoimmun 31 (2008) 201-207
5. Imrell K., Greiner E., Hillert J., and Masterman T. HLA-DRB1*15 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis. J Neuroimmunol 210 (2009) 128-130
6. Vasconcelos C.C., Fernández O., Leyva L., Thuler L.C., and Alvarenga R.M. Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis. J Neuroimmunol 214 (2009) 101-103
7. Arcos-Burgos M., Palacio G., Sánchez J.L., Londoño A.C., Uribe C.S., Jiménez M., et al. Multiple sclerosis: association to HLA DQalpha in a tropical population. Exp Clin Immunogenet 16 (1999) 131-138
8. Anaya J.M., Gomez L., and Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 13 (2006) 185-195
9. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
10. Correa P.A., Whitworth W.C., Kuffner T., McNicholl J., and Anaya J.M. HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. Tissue Antigens 59 (2002) 436-439
11. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
12. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
13. Holdsworth R., Hurley C.K., Marsh S.G., Lau M., Noreen H.J., Kempenich J.H., et al. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 73 (2009) 95-170
14. Carvalho A., Sant'anna G., Santos C.C., Frugulhetti I.P., Leon S.A., and Quírico-Santos T. Determination of autoantibody for myelin antigens in the serum of patients HLA-DQB1*0602 with multiple sclerosis. Arq Neuropsiquiatr 61 (2003) 968-973
15. Alves-Leon S.V., Papais-Alvarenga R., Magalhães M., Alvarenga M., Thuler L.C., and Fernández y.F.O. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand 115 (2007) 306-311
16. Aláez C., Corona T., Ruano L., Flores H., Loyola M., and Gorodezky C. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans. Acta Neurol Scand 112 (2005) 317-322
17. Alvarado-de la Barrera C., Zúñiga-Ramos J., Ruíz-Morales J.A., Estañol B., Granados J., and Llorente L. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology 55 (2000) 1897-1900
18. Brum D.G., Barreira A.A., Louzada-Junior P., Mendes-Junior C.T., and Donadi E.A. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil. J Neuroimmunol 189 (2007) 118-124
19. Patrucco L., Larriba J., Redal M.A., Rojas J.I., Argibay P.F., and Cristiano E. HLA-DRB1 and multiple sclerosis in Argentina. Eur J Neurol 16 (2009) 427-429
20. Kelly M.A., Jacobs K.H., Penny M.A., Mijovic C.H., Nightingale S., Barnett A.H., et al. An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin. Tissue Antigens 45 (1995) 197-202
21. Caballero A., Alvés-León S., Papais-Alvarenga R., Fernández O., Navarro G., and Alonso A. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Tissue Antigens 54 (1999) 524-526
22. Cirne-Santos C.C. Analysis of HLA DQ, DP, DR alleles associated with multiple sclerosis susceptibility in a population of patients from the Rio de Janeiro city. Arq Neuropsiquiatr 60 (2002) 1051
23. Quelvennec E., Bera O., Cabre P., Alizadeh M., Smadja D., Jugde F., et al. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Tissue Antigens 61 (2003) 166-171
24. Gorodezky C., Najera R., Rangel B.E., Castro L.E., Flores J., Velázquez G., et al. Immunogenetic profile of multiple sclerosis in Mexicans. Hum Immunol 16 (1986) 364-374
25. Haghighi S., Andersen O., Nilsson S., Rydberg L., and Wahlström J. A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy. Mult Scler 12 (2006) 723-730
26. Haegert D.G., Swift F.V., and Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 46 (1996) 1107-1111
27. Grau-López L., Raïch D., Ramo-Tello C., Naranjo-Gómez M., Dàvalos A., Pujol-Borrell R., et al. Myelin peptides in multiple sclerosis. Autoimmun Rev 8 (2009) 650-653
28. Ota K., Matsui M., Milford E.L., Mackin G.A., and Weiner H.L. Hafler DA.T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346 (1990) 183-187
29. Wucherpfennig K.W., Zhang J., Witek C., Matsui M., Modabber Y., Ota K., et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 152 (1994) 5581-5592
30. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 160 (1998) 3363-3373
31. Sidney J., del Guercio M.F., Southwood S., Engelhard V.H., Appella E., Rammensee H.G., et al. Several HLA alleles share overlapping peptide specificities. J Immunol 154 (1995) 247-259
32. Nielsen M., Lundegaard C., Blicher T., Peters B., Sette A., Justesen S., et al. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol 4 (2008) e1000107
33. Lund O., Nielsen M., Kesmir C., Petersen A.G., Lundegaard C., Worning P., et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55 (2004) 797-810
34. Warren K.G., and Catz I. Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP(85)VVHFFKNIVTP(96)RT in multiple sclerosis patients. Mult Scler 6 (2000) 300-311
35. Agudelo W.A., Galindo J.F., Ortiz M., Villaveces J.L., Daza E.E., and Patarroyo M.E. Variations in the electrostatic landscape of class II human leukocyte antigen molecule induced by modifications in the myelin basic protein peptide: a theoretical approach. PLoS ONE 4 (2009) e4164
36. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J.M., and Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108 (2007) 567-577
37. Pender M.P. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimmun Rev 8 (2009) 563-568
38. Lünemann J.D., Jelcić I., Roberts S., Lutterotti A., Tackenberg B., Martin R., et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 205 (2008) 1763-1773
39. De Jager P.L., Simon K.C., Munger K.L., Rioux J.D., Hafler D.A., and Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70 13 Pt 2 (2008) 1113-1118
40. Correale J. MS in Latin America. Int MS J 15 (2008) 3-5